Skip to content

Effect of Oat Compounds on Postprandial Glucose Response

Synergistic Effect of Oat Beta-glucans and Oat Polar Lipids on Postprandial Glucose Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05177172
Enrollment
20
Registered
2022-01-04
Start date
2021-12-01
Completion date
2022-01-19
Last updated
2022-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

Prevention, food, diabetes type 2, postprandial glucose regulation, appetite, oat, polar lipids, obesity, glucose tolerance

Brief summary

In this project we will investigate synergistic effects of oat polar lipids and beta glucans on postprandial glucose tolerance

Interventions

OTHERHigh beta glucans

higher dose betaglucans

OTHERLow beta glucans

lower dose beta glucans

OTHERLow beta glucans + low polar lipids

low dose betaglucans in a combination with low dose of polar lipids

OTHERPolar lipids

low dose polar lipids

OTHERControl

No beta glucans or polar lipids

Sponsors

Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Four test products and one reference product (control). Participants are not aware of which product that is served at each visits

Intervention model description

Randomised food study in healthy subjects

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * BMI 20-28 kg/m2 * Diet which follows the Nordic Nutrition Recommendations (non-vegetarian)

Exclusion criteria

* fasting glucose \> 6.1 mmol/L * metabolic diseases * gastrointestinal disease * chronic and/or psychological disease * food allergy * Vegetarian or vegan diets, or other special diets

Design outcomes

Primary

MeasureTime frameDescription
Glucose tolerance3 hours. Fasting (time =0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutesPostprandial glucose concentrations (mmol/L). The incremental area under the curve will be calculated and expressed as mmol\*minutes/litre.

Secondary

MeasureTime frameDescription
Subjective appetite variables3 hours. Fasting (time =0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutesPostprandial sensation of hunger, satiety, and desire to eat will be determined with a 100 millimeter visual analogue scale (VAS). The left end of the VAS scale represent not at all (e.g. hungry) and right end of the scale represented extremely. One scale for each parameter will be used. The total area under the curve will be calculated, and the results will be expressed as millimeter\*minutes.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026